Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Recruiting Observational

Cardiac Normal Values Assessed by Magnetic Resonance Imaging

NCT05346094 · tracked via the Priya Life Science China tracker
Phase
Observational
Started
2022-01-01
Last updated
2023-01-04

Condition(s) studied

Healthy ParticipantsReference Values

Investigational drug(s) / intervention(s)

No intervention

No intervention: No intervention

Study summary

This study carried out a study enrolled healthy volunteers to comprehensively provide age and sex specific reference values of the normal cardiac structure and function of Chinese adults, using the steady-state free precession technique (SSFP) as well as reference values for novel cardiovascular magnetic resonance techniques including myocardial strian and tissue characterization.

Eligibility

Sex
ALL
Min age
—
Max age
80 Years
Healthy volunteers
Accepted
Inclusion Criteria: Subjects without cardiovascular disease, cardiovascular related symptoms and risk factors judged by combining clinical manifestations, non-invasive imaging and laboratory examination Exclusion Criteria: * Subjects clinically screened or previously diagnosed with cardiovascular disease and risk factors * Subjects with serious non-cardiovascular diseases * Subjects with poor quality of magnetic resonance imaging * Subjects refused to participate in the study * Subjects with contraindications to MRI

Primary outcome measure(s)

  • Normal values of left and right structures and cardiac function — 5 years
    Create a database for normal values of left and right structures and cardiac function
  • Normal values of novel cardiovascular magnetic resonance parameters — 5 years
    Create a database for normal values of novel cardiovascular magnetic resonance parameters

Trial sites (1)

FacilityCityRegionStatus
Fuwai Hospital Beijing Beijing Municipality Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05346094 on ClinicalTrials.gov ↗ ← All trials in China